Evidence map›Paper›PMID 35631226›Full record

ArticleNutrients2022

Phospholipid Profiles Are Selectively Altered in the Putamen and White Frontal Cortex of Huntington's Disease.

Gabrielle R Phillips, Sarah E Hancock, Andrew M Jenner, Catriona McLean, Kelly A Newell, Todd W Mitchell

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  2. Article
  3. Lysosomal homeostasis at the crossroads of neurodegeneration.The Journal of clinical investigation · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Gabrielle R PhillipsIllawarra Health and Medical Research Institute, University of Wollongong, Wollongong 2522, Australia.ORCID 0000-0001-9014-2771
Sarah E HancockSchool of Medical Sciences, University of New South Wales, Sydney 2052, Australia.
Andrew M JennerBioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney 2052, Australia.
Catriona McLeanDepartment of Anatomical Pathology, Alfred Health and Florey Neuroscience, Parkville 3052, Australia.
Kelly A NewellIllawarra Health and Medical Research Institute, University of Wollongong, Wollongong 2522, Australia.
Todd W MitchellIllawarra Health and Medical Research Institute, University of Wollongong, Wollongong 2522, Australia.
University of Wollongong · AUAlfred Health · AUThe University of Sydney · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Huntington's disease (HD) is a genetic, neurodegenerative illness that onsets in late adulthood as a series of progressive and terminal cognitive, motor, and psychiatric deficits. The disease is caused by a polyQ mutation in the Huntingtin gene (

Indexed as

Huntington DiseaseAdultEstersFrontal LobeHumansPhospholipidsPutamenEstersPhospholipidscortexHuntington’s diseaselipidsphospholipidsstriatumwhite matter

Identifiers

PMID35631226
PMCPMC9143248
OpenAlexW4280582235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.